Danaher Corp at Evercore ISI HealthCONx Conference (Virtual) Transcript
Okay. Thanks, everyone, for joining us this morning. I'm Vijay Kumar. I cover life sciences and med tech at Evercore. A real pleasure to have with us Danaher. Representing the company, we have the CEO, Rainer Blair. We have the CFO, Matt McGrew. And plus from IR, we have Matt Gugino. Gentlemen, thanks for taking the time this morning. And Rainer, excited to have you on your first public, I guess, conference call with investors perhaps in a more formal setting, if you will.
Questions & Answers
Maybe we'll start with some topical questions, Rainer, if you don't mind. Second wave has been a topical question for people. How should we think about this rising second wave and perhaps impact on the business? It looks like the 3Q step-up -- sequential step-up in 3Q versus 2Q was pretty remarkable. It came in above expectations. But perhaps, should we be a little bit more cautious into Q4? How
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |